HK Stock Price Fluctuated | ALI PICTURES (01060) has risen over 5%. Its revenue and profit in the first half of the year have both grown rapidly. Morgan Stanley considers its valuation to be attractive.
Connect the global capital markets.
ALI PICTURES (01060) rose more than 5%, and as of press time, it increased by 5.66%, reaching HKD 0.56, with a trading volume of HKD 27.4983 million.
Anxin Securities stated that the recovery of offline entertainment and performance in the first half of the year has driven rapid growth in income and profits for ALI PICTURES. The ticketing industry for performances has obvious characteristics of supply-driven demand. In the medium and long term, the integration of the Dami business and the deep layout of the industry chain will be the new revenue growth engine, and AIGC is expected to improve profit margins through cost reduction and efficiency improvement in content production and promotion. The company's performance is in a strong recovery channel, and investors are advised to pay attention to it.
Morgan Stanley pointed out that the Dami business acquired by the group is expected to bring a gross profit of 700-800 million yuan to the group in the 2025 fiscal year, equivalent to an increase of about 30-40 percentage points. In addition, the group's movie content and ticketing are steadily growing, with reasonable ticket subsidies and healthy competition, and it is expected that ALI PICTURES will continue to gain market share in the upstream content field. The bank maintains an "overweight" rating for ALI PICTURES, and the target price has been raised from HKD 0.61 to HKD 0.68, with attractive valuation.
Related Articles

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.
SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


